Mirae Asset Global Investments Co., Ltd. Natera, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 307,716 shares of NTRA stock, worth $32.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
307,716
Previous 86,199
256.98%
Holding current value
$32.8 Million
Previous $5.4 Million
421.26%
% of portfolio
0.05%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding NTRA
# of Institutions
439Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.18 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$783 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$697 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$690 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$418 Million1.67% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...